Related Experiment Video
Updated: Apr 16, 2026
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
Diagnostic accuracy of diffusion MRI with quantitative ADC measurements in differentiating glioma recurrence from
Hui Zhang1, Li Ma2, Cheng Shu1
1Department of Neurosurgery, Air Force General Hospital of the Chinese PLA, 30 Fucheng Road, Haidian District, Beijing 100142, China.
Objective:
Differentiating radiation necrosis from glioma recurrence remains a great challenge. Several advanced imaging modalities have been developed to differentiate between these two entities with disparate outcomes. We conducted a meta-analysis to evaluate the diagnostic quality of diffusion MRI in differentiating glioma recurrence from radiation necrosis.
Method:
PubMed, Embase and Chinese Biomedical databases were systematically searched to identify published articles about evaluation of diffusion MRI for the differential diagnosis of glioma recurrence from radiation necrosis. Pooled sensitivity (SEN), specificity (SPE), negative likelihood ratio (NLR), positive likelihood ratio (PLR), and diagnostic odds ratio (DOR) were calculated.
Results:
Nine studies involving 284 patients (288 lesions) met all inclusion and exclusion criteria. Quantitative synthesis of studies showed that the pooled weighted values were determined to be SEN: 0.82 (95% CI: 0.75, 0.87); SPE: 0.84 (95% CI: 0.76, 0.91); PLR: 5.10 (95% CI: 3.27, 7.95); NLR: 0.21 (95% CI: 0.15, 0.29); and DOR: 23.90 (95% CI: 12.44, 45.89).
Conclusions:
This meta-analysis shows that diffusion MRI has moderate diagnostic performance in differentiating glioma recurrence from radiation necrosis using quantitative ADC. It is recommended not to use diffusion MRI alone in differentiating between glioma recurrence and radiation necrosis. Multimodal imaging trials should be implemented in the future.
Insights
Differentiating radiation necrosis from glioma recurrence is challenging. Diffusion MRI shows moderate accuracy, but multimodal imaging is recommended for definitive diagnosis.
Area of Science:
- Neuro-oncology
- Radiology
- Medical Imaging
Background:
- Distinguishing between radiation necrosis and glioma recurrence is critical for patient management.
- Both conditions present similar imaging characteristics, posing a diagnostic challenge.
- Advanced imaging techniques are being explored to improve diagnostic accuracy.
Purpose of the Study:
- To evaluate the diagnostic performance of diffusion MRI in differentiating recurrent glioma from radiation necrosis.
- To conduct a meta-analysis of existing studies on diffusion MRI for this specific diagnostic task.
Main Methods:
- Systematic literature search of PubMed, Embase, and Chinese Biomedical databases.
- Inclusion of studies evaluating diffusion MRI for differentiating glioma recurrence from radiation necrosis.
- Calculation of pooled sensitivity, specificity, likelihood ratios, and diagnostic odds ratio.
Main Results:
- Nine studies with 284 patients (288 lesions) were included.
- Pooled sensitivity was 0.82 (95% CI: 0.75, 0.87) and pooled specificity was 0.84 (95% CI: 0.76, 0.91).
- Diagnostic odds ratio was 23.90 (95% CI: 12.44, 45.89), indicating moderate performance.
Conclusions:
- Diffusion MRI demonstrates moderate diagnostic capability in differentiating glioma recurrence from radiation necrosis based on quantitative apparent diffusion coefficient (ADC) values.
- Diffusion MRI alone is not sufficient for definitive differentiation.
- Future multimodal imaging trials are recommended to enhance diagnostic accuracy.
